Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-23-000004

Director acquired 1,725 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Dubin Glenn Director 2023-01-03 Grant or award +1,725 $6.38 $11,006 5,235 D
Loading xslF345X03/wf-form4_167286693048091.xml…